Legal highs’, PMMA and zombie panic

Ecstasy, legal highs and designer drug use: A Canadian perspective

From Drug Science Policy and Law

Recent deaths in both Canada and the UK linked to PMA/PMMA in ecstasy pills has brought public scrutiny to this little known drug. With Canadian producing most of the ecstasy in the North American market, this timely paper looks at trends in ecstasy adulteration, the facts around PMA/PMMA-linked deaths and explores alternatives to the endless banning of new drugs.

 

Abstract

Recreational drug use in Canada is not uncommon, but as with most societies, illegal drug use carries harsh penalties resulting in a criminal record when an individual is successfully prosecuted. Popular drugs of use in Canada include ecstasy, cannabis (including some synthetic cannabinoids sold as ‘Spice’ and ‘Incense’) and several emerging psychoactive ‘legal highs’. Surprisingly, Canada is a major manufacturer and exporter of the popular club drug ecstasy, with criminal gangs organising the synthesis and distribution of this club drug worldwide. Over the last 18 months, there has been much interest in and use of alternatives to ecstasy due to contamination of ecstasy during synthesis. One particular contaminant, paramethoxymethamphetamine (PMMA), has resulted in several deaths. Other alternatives include piperazines and mephedrone analogues. With regard to cannabis, some is home grown within people’s properties, but there is also large-scale cultivation in British Columbia where the climate is more temperate. With the introduction of corporate drug screening, there is increasing use of synthetic cannabinoids to avoid detection of marijuana use. This article discusses the problems and trends of synthetic drug use in Canada and reflects on the limited education available to youth in this regard.

 

 

Read this article for free

Article details

Alan L Hudson, Maggie D Lalies, Glen B Baker, Kristopher Wells, and Katherine J Aitchison
Ecstasy, legal highs and designer drug use: A Canadian perspective Drug Science, Policy and Law January 2013 – December 2014 1: 2050324513509190, first published on February 10, 2014 doi:10.1177/2050324513509190

 

 

 

 

     
This entry was posted in Medicine, SAGE Insight and tagged , , , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

Please type the characters of this captcha image in the input box

Please type the characters of this captcha image in the input box

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>